| scholarly article | Q13442814 |
| P50 | author | Peter Calabresi | Q7173149 |
| Matthew D Smith | Q39186985 | ||
| Michael D. Kornberg | Q40354759 | ||
| P2093 | author name string | Solomon H Snyder | |
| Hasti Atashi Shirazi | |||
| Paul M Kim | |||
| P2860 | cites work | Cognitive impairment in multiple sclerosis | Q28300777 |
| Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis | Q28591514 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Bryostatins: biological context and biotechnological prospects. | Q34145397 | ||
| Bryostatin-1, a naturally occurring antineoplastic agent, acts as a Toll-like receptor 4 (TLR-4) ligand and induces unique cytokines and chemokines in dendritic cells | Q34452508 | ||
| Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice | Q34549472 | ||
| The clinical development of the bryostatins | Q34789777 | ||
| Virtues and pitfalls of EAE for the development of therapies for multiple sclerosis | Q36254088 | ||
| Bryostatin-1: pharmacology and therapeutic potential as a CNS drug. | Q36533472 | ||
| A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma | Q36671119 | ||
| Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system | Q37198963 | ||
| M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination | Q37687158 | ||
| Progressive multiple sclerosis: pathology and pathogenesis | Q38046113 | ||
| The "memory kinases": roles of PKC isoforms in signal processing and memory formation | Q38183975 | ||
| Relapsing and progressive forms of multiple sclerosis: insights from pathology | Q38203770 | ||
| Animal models of Multiple Sclerosis. | Q38396248 | ||
| A basic overview of multiple sclerosis immunopathology | Q38587668 | ||
| E6020, a synthetic TLR4 agonist, accelerates myelin debris clearance, Schwann cell infiltration, and remyelination in the rat spinal cord | Q38934165 | ||
| Acute oral Bryostatin-1 administration improves learning deficits in the APP/PS1 transgenic mouse model of Alzheimer's disease | Q39071776 | ||
| IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice | Q39769143 | ||
| Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators | Q39784350 | ||
| Protein Kinase Cϵ (PKCϵ) Promotes Synaptogenesis through Membrane Accumulation of the Postsynaptic Density Protein PSD-95 | Q42037616 | ||
| PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice | Q44962410 | ||
| Bryostatin-1 restores hippocampal synapses and spatial learning and memory in adult fragile x mice | Q44995758 | ||
| Type II monocytes modulate T cell-mediated central nervous system autoimmune disease | Q46463050 | ||
| Endotoxin can induce MyD88-deficient dendritic cells to support T(h)2 cell differentiation | Q74405327 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2186-2191 | |
| P577 | publication date | 2018-02-12 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Bryostatin-1 alleviates experimental multiple sclerosis | |
| P478 | volume | 115 |
| Q93101907 | Bryostatin-1 ameliorated experimental colitis in Il-10-/- Mice by protecting the intestinal barrier and limiting immune dysfunction |
| Q92992603 | Glutamine antagonism attenuates physical and cognitive deficits in a model of MS |
| Q55483693 | Inhibition of Inflammation, Suppression of Matrix Metalloproteinases, Induction of Neurogenesis, and Antioxidant Property Make Bryostatin-1 a Therapeutic Choice for Multiple Sclerosis. |
| Q60934126 | Regulation of Neural Stem Cell Fate by Natural Products |
| Q92711767 | Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling |
| Q92092942 | Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy |
| Q64061544 | Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis |
Search more.